{"DataElement":{"publicId":"2974177","version":"1","preferredName":"Hematopoietic Cell Transplantation Primary Disease Classification Central Nervous System Neoplasm Type","preferredDefinition":"A description of the primary central nervous system disease for which the hematopoietic cell transplantation was performed.","longName":"2540957v2.0:2962176v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2540957","version":"2","preferredName":"Hematopoietic Cell Transplantation Primary Disease Classification","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_The grafting of tissues from one individual to another or place to place within a single individual._Occurring first in time or sequence; original; of greatest rank or importance or value._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. Sometimes the term is used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"HSCT_PRM_DS_CLS","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"3767215","version":"1","preferredName":"Hematopoietic Stem Cell Transplantation Primary Disease or Disorder","preferredDefinition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.):The grafting of tissues from one individual to another or place to place within a single individual.:Occurring first in time or sequence; original; of greatest rank or importance or value.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","longName":"C12551:C15342:C25251:C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Transplantation","conceptCode":"C15342","definition":"Transference of a tissue or organ within an individual, between individuals of the same species, or between individuals of different species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DD3C365C-249C-F375-E040-BB89AD4325C1","latestVersionIndicator":"Yes","beginDate":"2013-05-21","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-05-21","modifiedBy":"ONEDATA","dateModified":"2013-05-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2321361","version":"1","preferredName":"Classification","preferredDefinition":"Classification; the grouping of things into classes or categories.","longName":"C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCF89106-20AF-2D93-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-29","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-29","modifiedBy":"ONEDATA","dateModified":"2005-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"CEF00533-513A-C704-E040-BB89AD433B42","latestVersionIndicator":"Yes","beginDate":"2012-11-20","endDate":null,"createdBy":"NYCHM","dateCreated":"2012-11-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2962176","version":"1","preferredName":"Central Nervous System Neoplasm Type","preferredDefinition":"Abnormal growth of cells that comprise the tissues of the central nervous system (brain and spinal cord), without designation of benign or malignant nature._Something distinguishable as an identifiable class based on common qualities.","longName":"2962176v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"70","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Aggressive low-grade glial tumors","valueDescription":"Aggressive Low Grade Neuroglial Tumor","ValueMeaning":{"publicId":"2962190","version":"1","preferredName":"Aggressive Low Grade Neuroglial Tumor","longName":"2962190","preferredDefinition":"A quickly growing cancer.: denoting slow growth; indolent.: A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells).  Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas.  Tumors that arise from oligodendrocytes are called oligodendroglial tumors.  Tumors that arise from ependymal cells are called ependymomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aggressive","conceptCode":"C14138","definition":"Describes a tumor or condition that develops, grows, or spreads rapidly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Low Grade","conceptCode":"C14161","definition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Glioma","conceptCode":"C3059","definition":"A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells). Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas. Tumors that arise from oligodendrocytes are called oligodendroglial tumors. Tumors that arise from ependymal cells are called ependymomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BEF6A1-B022-4712-E040-BB89AD4372AF","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9B21-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Anaplastic (malignant) ependymoma","valueDescription":"Anaplastic ependymoma","ValueMeaning":{"publicId":"2572931","version":"1","preferredName":"Anaplastic ependymoma","longName":"2572931","preferredDefinition":"Anaplastic Ependymoma (WHO grade III) is a malignant glioma of ependymal origin with accelerated growth and an unfavorable clinical outcome, particularly in children. Anaplastic Ependymomas show high mitotic activity, often accompanied by microvascular proliferation and pseudo-palisading necrosis. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Ependymoma","conceptCode":"C4049","definition":"A WHO grade 3 malignant glioma of ependymal origin with accelerated growth and an unfavorable clinical outcome, particularly in children. It is characterized by high mitotic activity, often accompanied by microvascular proliferation and pseudo-palisading necrosis. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9F0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9B35-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Anaplastic astroblastoma","valueDescription":"Anaplastic Astroblastoma","ValueMeaning":{"publicId":"2962188","version":"1","preferredName":"Anaplastic Astroblastoma","longName":"2962188","preferredDefinition":"An astroblastoma characterized by the presence of high mitotic activity, cytologic atypia, and architectural distortion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Astroblastoma, MN1-Altered","conceptCode":"C84347","definition":"An astroblastoma, MN1-altered, characterized by the presence of high mitotic activity, cytologic atypia, and architectural distortion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BEF6A1-AFFA-4712-E040-BB89AD4372AF","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9B49-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Anaplastic astrocytoma","valueDescription":"Anaplastic astrocytoma","ValueMeaning":{"publicId":"2572930","version":"1","preferredName":"Anaplastic astrocytoma","longName":"2572930","preferredDefinition":"A diffusely infiltrating, WHO grade III astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Astrocytoma","conceptCode":"C9477","definition":"A diffusely infiltrating, WHO grade 3 astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9EF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9B53-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Anaplastic mixed glioma","valueDescription":"Anaplastic oligoastrocytoma","ValueMeaning":{"publicId":"2568646","version":"1","preferredName":"Anaplastic oligoastrocytoma","longName":"2568646","preferredDefinition":"Anaplastic Oligoastrocytoma is an Oligoastrocytoma with histological features of malignancy, such as increased cellularity, nuclear atypia, pleomorphism, and increased mitotic activity. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Oligoastrocytoma","conceptCode":"C6959","definition":"An oligoastrocytoma characterized by the presence of increased cellularity, nuclear atypia, pleomorphism, and high mitotic activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D933-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9B67-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Anaplastic oligodendroglioma","valueDescription":"Anaplastic oligodendroglioma","ValueMeaning":{"publicId":"2572933","version":"1","preferredName":"Anaplastic oligodendroglioma","longName":"2572933","preferredDefinition":"A WHO grade III oligodendroglioma with focal or diffuse malignant morphologic features (prominent nuclear pleomorphism, mitoses, and increased cellularity).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Oligodendroglioma","conceptCode":"C4326","definition":"A WHO grade 3 oligodendroglioma with focal or diffuse malignant morphologic features (prominent nuclear pleomorphism, mitoses, and increased cellularity).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9F2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9B71-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Brainstem PNET","valueDescription":"Brain Stem Primitive Neuroectodermal Tumor","ValueMeaning":{"publicId":"2962187","version":"1","preferredName":"Brain Stem Primitive Neuroectodermal Tumor","longName":"2962187","preferredDefinition":"The part of the brain that is connected to the spinal cord.: A malignant neoplasm that originates in the neuroectoderm. The neuroectoderm constitutes the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems and includes some glial cell precursors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brain Stem","conceptCode":"C12441","definition":"Three sections, the midbrain, pons and medulla oblongata, that are located at the base of the brain. The brain stem regulates the central nervous system, and is vital as a conduit for motor and sensory innervations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Primitive Neuroectodermal Tumor","conceptCode":"C3716","definition":"A malignant neoplasm that originates in the neuroectoderm. The neuroectoderm constitutes the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems and includes some glial cell precursors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BEF6A1-AF85-4712-E040-BB89AD4372AF","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9B85-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Brainstem tumor with pathologic diagnosis","valueDescription":"Brain Stem Neoplasm With Pathologic","ValueMeaning":{"publicId":"2974079","version":"1","preferredName":"Brain Stem Neoplasm With Pathologic","longName":"2974079","preferredDefinition":"Abnormal growth of cells in the brain stem. It is important to note that even if the cells comprising this tumor are histologically benign, the prognosis can be grim due to the tumor's location. Overall, though some of these tumors have a slightly better prognosis (patients with dorsally exophytic tumors fare slightly better) the 5-ear survival is less than forty percent. Intraaxial brain stem neoplasms can be associated with neuro-ophthalmologic signs that can assist in localization even prior to definitive imaging.: Used to indicate the presence of something or someone.: Pathologic; caused by or altered by or manifesting disease or pathology.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brain Stem Neoplasm","conceptCode":"C4869","definition":"A benign or malignant neoplasm that affects the brain stem.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCE5DFC-2972-AF37-E040-BB89AD4368D2","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-12-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9B99-5454-E040-BB89AD433337","beginDate":"2009-12-28","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Brainstem tumor without pathologic diagnosis","valueDescription":"Brain Stem Neoplasm Without Pathologic","ValueMeaning":{"publicId":"2962186","version":"1","preferredName":"Brain Stem Neoplasm Without Pathologic","longName":"2962186","preferredDefinition":"Abnormal growth of cells in the brain stem. It is important to note that even if the cells comprising this tumor are histologically benign, the prognosis can be grim due to the tumor's location. Overall, though some of these tumors have a slightly better prognosis (patients with dorsally exophytic tumors fare slightly better) the 5-ear survival is less than forty percent. Intraaxial brain stem neoplasms can be associated with neuro-ophthalmologic signs that can assist in localization even prior to definitive imaging.: Used to indicate the absence or lack of something or someone. (from Merriam-Webster OnLine): Pathologic; caused by or altered by or manifesting disease or pathology.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brain Stem Neoplasm","conceptCode":"C4869","definition":"A benign or malignant neoplasm that affects the brain stem.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Without","conceptCode":"C25718","definition":"Used to indicate the absence or lack of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BEF6A1-AF5B-4712-E040-BB89AD4372AF","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9BAD-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Cellular (low-grade) ependymoma","valueDescription":"Cellular Ependymoma","ValueMeaning":{"publicId":"2962184","version":"1","preferredName":"Cellular Ependymoma","longName":"2962184","preferredDefinition":"Cellular Ependymoma is a variant of Ependymoma which shows conspicuous cellularity without a significant increase in mitotic rate. (Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cellular Ependymoma","conceptCode":"C4713","definition":"An ependymoma which shows conspicuous cellularity without a significant increase in mitotic rate. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BEF6A1-AF33-4712-E040-BB89AD4372AF","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9BC1-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Cerebral neuroblastoma/PNET","valueDescription":"Cerebral Neuroblastoma Or Primitive Neuroectodermal Tumor","ValueMeaning":{"publicId":"2962182","version":"1","preferredName":"Cerebral Neuroblastoma Or Primitive Neuroectodermal Tumor","longName":"2962182","preferredDefinition":"A neuroblastoma arising from the cerebral hemispheres.: Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: A malignant neoplasm that originates in the neuroectoderm. The neuroectoderm constitutes the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems and includes some glial cell precursors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System Neuroblastoma","conceptCode":"C4826","definition":"A neuroblastoma arising from the central nervous system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Primitive Neuroectodermal Tumor","conceptCode":"C3716","definition":"A malignant neoplasm that originates in the neuroectoderm. The neuroectoderm constitutes the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems and includes some glial cell precursors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BEF6A1-AF0D-4712-E040-BB89AD4372AF","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9BD5-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Ependymoblastoma","valueDescription":"Ependymoblastoma","ValueMeaning":{"publicId":"2568654","version":"1","preferredName":"Ependymoblastoma","longName":"2568654","preferredDefinition":"An aggressive malignant embryonal neoplasm arising from the central nervous system. It is characterized by the presence of multilayered rosettes formation, and increased cellularity. Symptoms include increased intracranial pressure, hydrocephalus, and focal neurological signs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Embryonal Tumor with Multilayered Rosettes, C19MC-Altered","conceptCode":"C4915","definition":"An aggressive embryonal tumor with multilayered rosettes characterized by the presence of amplification of the C19MC region on chromosome 19 (19q13.42).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D93B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-11","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9BDF-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Glioblastoma multiforme","valueDescription":"Glioblastoma","ValueMeaning":{"publicId":"2578734","version":"1","preferredName":"Glioblastoma","longName":"2578734","preferredDefinition":"A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glioblastoma","conceptCode":"C3058","definition":"The most malignant astrocytic tumor (WHO grade 4).  It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-009B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"ONEDATA","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9BF3-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Medulloblastoma/Posterior fossa PNET","valueDescription":"Medulloblastoma","ValueMeaning":{"publicId":"2578699","version":"1","preferredName":"Medulloblastoma","longName":"2578699","preferredDefinition":"A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Medulloblastoma","conceptCode":"C3222","definition":"A malignant, invasive embryonal neoplasm arising from the cerebellum or posterior fossa. It occurs predominantly in children and has the tendency to metastasize via the cerebrospinal fluid pathways. Signs and symptoms include truncal ataxia, disturbed gait, lethargy, headache, and vomiting. There are four histologic variants: classic medulloblastoma, large cell/anaplastic medulloblastoma, desmoplastic/nodular medulloblastoma, and medulloblastoma with extensive nodularity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0078-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9C07-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Mixed tumors with immature/mature teratoma elements","valueDescription":"Mixed Neoplasm With Central Nervous System Immature Teratoma Or Central Nervous System Mature Teratoma","ValueMeaning":{"publicId":"2974077","version":"1","preferredName":"Mixed Neoplasm With Central Nervous System Immature Teratoma Or Central Nervous System Mature Teratoma","longName":"2974077","preferredDefinition":"A tumor composed of at least two distinct cellular populations.: Used to indicate the presence of something or someone.: Immature Teratoma is a variant of Teratoma composed of incompletely differentiated components resembling fetal tissues. Even if the immature component is only a minor element of an otherwise differentiated tumor, the tumor is still classified as immature. (Adapted from WHO.): Or; used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Mature Teratomas are tumors composed exclusively of fully differentiated, 'adult-type' tissue elements that are sometimes arranged in a pattern resembling normal tissue relationships. Mitotic activity is low or absent. The more common ectodermal components found in Mature Teratomas include skin, brain and choroid plexus. The more common mesodermal components include cartilage, bone, fat and muscle (both smooth and striated). And the most common endodermal components are cysts lined by epithelia of respiratory or enteric type and in some cases pancreatic or hepatic tissue.  (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Neoplasm","conceptCode":"C6930","definition":"A neoplasm composed of at least two distinct cellular populations.","evsSource":"RADLEX_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Central Nervous System Immature Teratoma","conceptCode":"C7014","definition":"A teratoma involving the central nervous system and characterized by the presence of an extensive component of immature, fetal-type tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Central Nervous System Mature Teratoma","conceptCode":"C7013","definition":"A mature teratoma arising in the central nervous system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCE5DFC-2923-AF37-E040-BB89AD4368D2","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-12-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9C1B-5454-E040-BB89AD433337","beginDate":"2009-12-28","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Other high-grade glial tumor","valueDescription":"Other High Grade Neuroglial Tumor","ValueMeaning":{"publicId":"2962180","version":"1","preferredName":"Other High Grade Neuroglial Tumor","longName":"2962180","preferredDefinition":"Different than the one(s) previously specified or mentioned.: denoting fast growth.: A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells).  Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas.  Tumors that arise from oligodendrocytes are called oligodendroglial tumors.  Tumors that arise from ependymal cells are called ependymomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"High Grade","conceptCode":"C14158","definition":"Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Glioma","conceptCode":"C3059","definition":"A benign or malignant brain and spinal cord tumor that arises from glial cells (astrocytes, oligodendrocytes, ependymal cells). Tumors that arise from astrocytes are called astrocytic tumors or astrocytomas. Tumors that arise from oligodendrocytes are called oligodendroglial tumors. Tumors that arise from ependymal cells are called ependymomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BEF6A1-AEA9-4712-E040-BB89AD4372AF","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9C2F-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Other PNET","valueDescription":"Other Primitive Neuroectodermal Tumor","ValueMeaning":{"publicId":"2962179","version":"1","preferredName":"Other Primitive Neuroectodermal Tumor","longName":"2962179","preferredDefinition":"Different than the one(s) previously specified or mentioned.: A malignant neoplasm that originates in the neuroectoderm. The neuroectoderm constitutes the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems and includes some glial cell precursors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Primitive Neuroectodermal Tumor","conceptCode":"C3716","definition":"A malignant neoplasm that originates in the neuroectoderm. The neuroectoderm constitutes the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems and includes some glial cell precursors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BEF6A1-AE82-4712-E040-BB89AD4372AF","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9C43-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Pineoblastoma/Pineal region PNET","valueDescription":"Pineoblastoma","ValueMeaning":{"publicId":"2578700","version":"1","preferredName":"Pineoblastoma","longName":"2578700","preferredDefinition":"Pineoblastoma (WHO grade IV) is a highly malignant, primitive embryonal neoplasm, which occurs more commonly in children. It is composed of patternless sheets of densely packed small cells with round-to-irregular nuclei and scant cytoplasm, similar to medulloblastoma and related primitive neuroectodermal tumors. A frequent complication is metastasis via cerebrospinal fluid pathways, which is often associated with a fatal outcome. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pineoblastoma","conceptCode":"C9344","definition":"A poorly differentiated malignant embryonal neoplasm arising from the pineal region.  It usually occurs in children and it is characterized by the presence of small immature neuroepithelial cells.  It may follow an aggressive clinical course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0079-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9C57-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Primary brain sarcomas","valueDescription":"Primary Brain Sarcoma","ValueMeaning":{"publicId":"2974078","version":"1","preferredName":"Primary Brain Sarcoma","longName":"2974078","preferredDefinition":"Occurring first in time or sequence; original. (American Heritage Dictionary): A malignant mesenchymal neoplasm arising from the brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Brain Sarcoma","conceptCode":"C5154","definition":"A sarcoma arising from the brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCE5DFC-294B-AF37-E040-BB89AD4368D2","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-12-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9C6B-5454-E040-BB89AD433337","beginDate":"2009-12-28","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Pure choriocarcinoma","valueDescription":"Choriocarcinoma","ValueMeaning":{"publicId":"2837860","version":"1","preferredName":"Choriocarcinoma","longName":"2837860","preferredDefinition":"An aggressive malignant tumor arising from trophoblastic cells.  The vast majority of cases arise in the uterus and represent gestational choriocarcinomas that derive from placental trophoblastic cells.  Approximately half of the cases develop from a complete hydatidiform mole.  A minority of cases arise in the testis or the ovaries.  There is often marked elevation of human chorionic gonadotropin (hCG) in the blood.  Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected. --2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Choriocarcinoma","conceptCode":"C2948","definition":"An aggressive malignant tumor arising from trophoblastic cells. The vast majority of cases arise in the uterus and represent gestational choriocarcinomas that derive from placental trophoblastic cells. Approximately half of the cases develop from a complete hydatidiform mole. A minority of cases arise in the testis or the ovaries. There is often marked elevation of human chorionic gonadotropin (hCG) in the blood. Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6281C75A-491B-A127-E040-BB89AD431A41","latestVersionIndicator":"Yes","beginDate":"2009-02-09","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-09","modifiedBy":"ONEDATA","dateModified":"2009-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9C7F-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Pure endodermal sinus tumor","valueDescription":"Yolk Sac Tumor","ValueMeaning":{"publicId":"2838868","version":"1","preferredName":"Yolk Sac Tumor","longName":"2838868","preferredDefinition":"This is the most common malignant germ cell tumor in the pediatric population. Yolk sac tumors arise in the infant testis, ovary, sacrococcygeal region, vagina, uterus, prostate, abdomen, liver, retroperitoneum, thorax and pineal/third ventricle. The tumor mimics the yolk sac of the embryo and produces alpha-fetoprotein (AFP). Treatment includes: surgical resection, radiation and chemotherapy. This tumor is very responsive to chemotherapy regimens that include cisplatinum. - 2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yolk Sac Tumor","conceptCode":"C3011","definition":"A non-seminomatous malignant germ cell tumor composed of primitive germ cells.  It is the most common malignant germ cell tumor in the pediatric population. It occurs in the infant testis, ovary, sacrococcygeal region, vagina, uterus, prostate, abdomen, liver, retroperitoneum, thorax, and pineal/third ventricle. The tumor mimics the yolk sac of the embryo and produces alpha-fetoprotein (AFP). Treatment includes: surgical resection, radiation, and chemotherapy. This tumor is very responsive to chemotherapy regimens that include cisplatinum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A9E389-584E-FD59-E040-BB89AD432A90","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9C93-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Pure germinoma","valueDescription":"Germinoma","ValueMeaning":{"publicId":"2578733","version":"1","preferredName":"Germinoma","longName":"2578733","preferredDefinition":"The most common type of germ cell tumor affecting the central nervous system.  It is composed of uniform cells with large vesicular nuclei, prominent nucleoli and clear cytoplasm.  Lymphocytic or lymphoplasmacytic infiltrates are usually seen admixed with the tumor cells.  Less frequently giant syncytiotrophoblastic cells are also present.  Germinomas are usually radiosensitive and they have a favorable prognosis.  - 2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Germinoma","conceptCode":"C3753","definition":"A malignant germ cell tumor arising in the central nervous system. It is characterized by the presence of primitive, large malignant germ cells and lymphocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-009A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"REEVESD","dateModified":"2006-04-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9CA7-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Rhabdoid tumors","valueDescription":"Rhabdoid Tumor","ValueMeaning":{"publicId":"2962178","version":"1","preferredName":"Rhabdoid Tumor","longName":"2962178","preferredDefinition":"An aggressive malignant embryonal neoplasm usually occurring during childhood.  It is characterized by the presence of large cells with abundant cytoplasm, large eccentric nucleus, and a prominent nucleolus and it is associated with abnormalities of chromosome 22.  It can arise from the central nervous system, kidney, and the soft tissues.  The prognosis is poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rhabdoid Tumor","conceptCode":"C3808","definition":"An aggressive malignant embryonal neoplasm usually occurring during childhood.  It is characterized by the presence of large cells with abundant cytoplasm, large eccentric nucleus, and a prominent nucleolus and it is associated with abnormalities of chromosome 22.  It can arise from the central nervous system, kidney, and the soft tissues.  The prognosis is poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BEF6A1-AE0C-4712-E040-BB89AD4372AF","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8ABE4B65-9CBB-5454-E040-BB89AD433337","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","deletedIndicator":"No"},{"value":"Mixed tumors with pure endodermal sinus tumor and/or pure choriocarcinoma and pure germinoma","valueDescription":"Mixed Neoplasm With Yolk Sac Tumor And/Or Choriocarcinoma And Germinoma","ValueMeaning":{"publicId":"3131332","version":"1","preferredName":"Mixed Neoplasm With Yolk Sac Tumor And/Or Choriocarcinoma And Germinoma","longName":"3131332","preferredDefinition":"A tumor composed of at least two distinct cellular populations.: Used to indicate the presence of something or someone.: This is the most common malignant germ cell tumor in the pediatric population. Yolk sac tumors arise in the infant testis, ovary, sacrococcygeal region, vagina, uterus, prostate, abdomen, liver, retroperitoneum, thorax and pineal/third ventricle. The tumor mimics the yolk sac of the embryo and produces alpha-fetoprotein (AFP). Treatment includes: surgical resection, radiation and chemotherapy. This tumor is very responsive to chemotherapy regimens that include cisplatinum. - 2002: Used to indicate that either or both of two items or options: An aggressive malignant tumor arising from trophoblastic cells.  The vast majority of cases arise in the uterus and represent gestational choriocarcinomas that derive from placental trophoblastic cells.  Approximately half of the cases develop from a complete hydatidiform mole.  A minority of cases arise in the testis or the ovaries.  There is often marked elevation of human chorionic gonadotropin (hCG) in the blood.  Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected. --2004: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: The most common type of germ cell tumor affecting the central nervous system.  It is composed of uniform cells with large vesicular nuclei, prominent nucleoli and clear cytoplasm.  Lymphocytic or lymphoplasmacytic infiltrates are usually seen admixed with the tumor cells.  Less frequently giant syncytiotrophoblastic cells are also present.  Germinomas are usually radiosensitive and they have a favorable prognosis.  - 2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mixed Neoplasm","conceptCode":"C6930","definition":"A neoplasm composed of at least two distinct cellular populations.","evsSource":"RADLEX_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Yolk Sac Tumor","conceptCode":"C3011","definition":"A non-seminomatous malignant germ cell tumor composed of primitive germ cells.  It is the most common malignant germ cell tumor in the pediatric population. It occurs in the infant testis, ovary, sacrococcygeal region, vagina, uterus, prostate, abdomen, liver, retroperitoneum, thorax, and pineal/third ventricle. The tumor mimics the yolk sac of the embryo and produces alpha-fetoprotein (AFP). Treatment includes: surgical resection, radiation, and chemotherapy. This tumor is very responsive to chemotherapy regimens that include cisplatinum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Choriocarcinoma","conceptCode":"C2948","definition":"An aggressive malignant tumor arising from trophoblastic cells. The vast majority of cases arise in the uterus and represent gestational choriocarcinomas that derive from placental trophoblastic cells. Approximately half of the cases develop from a complete hydatidiform mole. A minority of cases arise in the testis or the ovaries. There is often marked elevation of human chorionic gonadotropin (hCG) in the blood. Choriocarcinomas disseminate rapidly through the hematogenous route; the lungs are most frequently affected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Germinoma","conceptCode":"C3753","definition":"A malignant germ cell tumor arising in the central nervous system. It is characterized by the presence of primitive, large malignant germ cells and lymphocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E80FBCD-B014-B2E9-E040-BB89AD4374AD","latestVersionIndicator":"Yes","beginDate":"2010-08-23","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-08-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E80FBCD-B02D-B2E9-E040-BB89AD4374AD","beginDate":"2010-08-23","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-08-23","modifiedBy":"ONEDATA","dateModified":"2010-08-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3118954","version":"1","preferredName":"Central Nervous System Neoplasm Type","preferredDefinition":"Abnormal growth of cells that comprise the tissues of the central nervous system (brain and spinal cord), without designation of benign or malignant nature.:Type; a subdivision of a particular kind of thing.","longName":"C9293:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System Neoplasm","conceptCode":"C9293","definition":"A benign or malignant, primary or metastatic neoplasm that affects the brain, meninges, or spinal cord.  Representative examples of primary neoplasms include astrocytoma, oligodendroglioma, ependymoma, and meningioma.  Representative examples of metastatic neoplasms include carcinoma and leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8ABE4B65-9905-5454-E040-BB89AD433337","latestVersionIndicator":"Yes","beginDate":"2010-07-06","endDate":null,"createdBy":"ZHANGW","dateCreated":"2010-07-06","modifiedBy":"ONEDATA","dateModified":"2010-07-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"78BEF6A1-ADF5-4712-E040-BB89AD4372AF","latestVersionIndicator":"Yes","beginDate":"2009-11-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-11-19","modifiedBy":"KUMMEROA","dateModified":"2020-12-16","changeDescription":". 2020-12-16 ak OK to release per WZ.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964893","version":"1","longName":"2025r1: Central Nervous System Tumor Pre-HSCT Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"cns_base_prim_dx_kn","type":"NMDP_FN","context":"NHLBI"},{"name":"Hematopoietic Stem Cell Transplantation Disease Primary Classification Central Nervous System Neoplasm Type","type":"System-Generated","context":"NHLBI"},{"name":"PerformedDiagnosis:value","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the primary central","type":"Preferred Question Text","description":"What was the primary central nervous system disease for which the hematopoietic cell transplantation was performed?","url":null,"context":"NHLBI"},{"name":"What was the primary disease for which the HSCT was performed?","type":"Alternate Question Text","description":"What was the primary disease for which the HSCT was performed?","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2974177","type":"BRIDG Mapping Path","description":"PerformedDiagnosis.value WHERE PerformedDiagnosis > DiagnosisProcedureRelationship > PerformedSubstanceAdministration > DefinedSubstanceAdministration.nameCode = \"Perform Overall hemopoietic stem cell transplantation\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCFB3FC-D8BC-5272-E040-BB89AD433A77","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-12-28","modifiedBy":"KUMMEROA","dateModified":"2020-12-16","changeDescription":". 2020-12-16 ak OK to release per WZ. System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}